Once a product is placed on import alert, FDA staff may hold incoming shipments without conducting physical testing or inspectiona process known as detention without physical examination or DWPE, as mentioned above
weakest in Authenticity (2.7/5) and Patient Protection (3.4/5)
Eli Lilly and Company), a combination GIP and GLP-1 receptor agonist, was FDA approved in 2022 to treat T2D and in 2023 to treat obesity.3 GLP-1 receptor agonists are known to possess positive cardiovascular effects
In animal studies, BPC-157 did not exhibit toxicity, even at high doses
Several distinct populations of microglia and macrophages have been described in the aging brain, including dark microglia (Kaya et al., 2022), and senescent-like microglia (Gross et al., 2025), underlying the heterogeneity of immune cell responses to aging-related stress